{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:11:26Z","timestamp":1757628686608,"version":"3.44.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"DOI":"10.1038\/s41371-025-01056-y","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T11:31:57Z","timestamp":1753788717000},"page":"666-674","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between bullous pemphigoid and hypertension: a systematic review and meta-analysis of observational studies"],"prefix":"10.1038","volume":"39","author":[{"given":"XiaoLi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XiaoRan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PanLing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JinPing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FuSheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZaiXing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"1056_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/bjd.19022","volume":"184","author":"MSM Persson","year":"2021","unstructured":"Persson MSM, Harman KE, Vinogradova Y, Langan SM, Hippisley-Cox J, Thomas KS, et al. Incidence, prevalence and mortality of bullous pemphigoid in England 1998-2017: a population-based cohort study. Br J Dermatol. 2021;184:68\u201377. https:\/\/doi.org\/10.1111\/bjd.19022","journal-title":"Br J Dermatol"},{"key":"1056_CR2","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/s0140-6736(17)30560-3","volume":"389","author":"HC Williams","year":"2017","unstructured":"Williams HC, Wojnarowska F, Kirtschig G, Mason J, Godec TR, Schmidt E, et al. Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial. Lancet. 2017;389:1630\u20138. https:\/\/doi.org\/10.1016\/s0140-6736(17)30560-3","journal-title":"Lancet"},{"key":"1056_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00403-020-02100-2","volume":"313","author":"S Lee","year":"2021","unstructured":"Lee S, Rastogi S, Hsu DY, Nardone B, Silverberg JI. Association of bullous pemphigoid and comorbid health conditions: a case-control study. Arch Dermatol Res. 2021;313:327\u201332. https:\/\/doi.org\/10.1007\/s00403-020-02100-2","journal-title":"Arch Dermatol Res"},{"key":"1056_CR4","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/1346-8138.15778","volume":"48","author":"K Chanprapaph","year":"2021","unstructured":"Chanprapaph K, Pratumchart N, Limtong P, Rutnin S, Sukasem C, Kungvalpivat P, et al. Dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid: a comparative study of 100 patients with bullous pemphigoid and diabetes mellitus. J Dermatol. 2021;48:486\u201396. https:\/\/doi.org\/10.1111\/1346-8138.15778","journal-title":"J Dermatol"},{"key":"1056_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/1346-8138.17100","volume":"51","author":"MJ He","year":"2024","unstructured":"He MJ, Wang YJ, Ran DL, Fu DS, He Q, Zhang HY, et al. Relationship between bullous pemphigoid and malignancy: a Mendelian randomization study. J Dermatol. 2024;51:403\u20138. https:\/\/doi.org\/10.1111\/1346-8138.17100","journal-title":"J Dermatol"},{"key":"1056_CR6","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/1346-8138.17577","volume":"52","author":"BR Kim","year":"2024","unstructured":"Kim BR, Lee KH, Paik K, Kim M, Bae JM, Choi CW, et al. Comorbid diseases in bullous pemphigoid: a population-based case-control study. J Dermatol. 2024;52:460\u201371. https:\/\/doi.org\/10.1111\/1346-8138.17577","journal-title":"J Dermatol"},{"key":"1056_CR7","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2338242","volume":"56","author":"A Moiz","year":"2024","unstructured":"Moiz A, Zolotarova T, Eisenberg MJ. Outpatient management of essential hypertension: a review based on the latest clinical guidelines. Ann Med. 2024;56:2338242 https:\/\/doi.org\/10.1080\/07853890.2024.2338242","journal-title":"Ann Med"},{"key":"1056_CR8","doi-asserted-by":"publisher","first-page":"e1000058","DOI":"10.1371\/journal.pmed.1000058","volume":"6","author":"G Danaei","year":"2009","unstructured":"Danaei G, Ding EL, Mozaffarian D, Taylor B, Rehm J, Murray CJ, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors. PLoS Med. 2009;6:e1000058 https:\/\/doi.org\/10.1371\/journal.pmed.1000058","journal-title":"PLoS Med"},{"key":"1056_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.17219\/acem\/90922","volume":"28","author":"A Kali\u0144ska-Bienias","year":"2019","unstructured":"Kali\u0144ska-Bienias A, Kowalczyk E, Jagielski P, Bienias P, Kowalewski C, Wo\u017aniak K. The association between neurological diseases, malignancies and cardiovascular comorbidities among patients with bullous pemphigoid: case-control study in a specialized polish center. Adv Clin Exp Med. 2019;28:637\u201342. https:\/\/doi.org\/10.17219\/acem\/90922","journal-title":"Adv Clin Exp Med"},{"key":"1056_CR10","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1111\/jdv.14312","volume":"31","author":"B Sim","year":"2017","unstructured":"Sim B, Fook-Chong S, Phoon YW, Koh HY, Thirumoorthy T, Pang SM, et al. Multimorbidity in bullous pemphigoid: a case-control analysis of bullous pemphigoid patients with age- and gender-matched controls. J Eur Acad Dermatol Venereol. 2017;31:1709\u201314. https:\/\/doi.org\/10.1111\/jdv.14312","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1056_CR11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1590\/abd1806-4841.20142516","volume":"89","author":"VB Teixeira","year":"2014","unstructured":"Teixeira VB, Cabral R, Brites MM, Vieira R, Figueiredo A. Bullous pemphigoid and comorbidities: a case-control study in portuguese patients. An Bras Dermatol. 2014;89:274\u20138. https:\/\/doi.org\/10.1590\/abd1806-4841.20142516","journal-title":"An Bras Dermatol"},{"key":"1056_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1161\/strokeaha.110.596361","volume":"42","author":"YW Yang","year":"2011","unstructured":"Yang YW, Chen YH, Xirasagar S, Lin HC. Increased risk of stroke in patients with bullous pemphigoid: a population-based follow-up study. Stroke. 2011;42:319\u201323. https:\/\/doi.org\/10.1161\/strokeaha.110.596361","journal-title":"Stroke"},{"key":"1056_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1684\/ejd.2018.3243","volume":"28","author":"A Pankakoski","year":"2018","unstructured":"Pankakoski A, Sintonen H, Ranki A, Kluger N. Comorbidities of bullous pemphigoid in a finnish cohort. Eur J Dermatol. 2018;28:157\u201361. https:\/\/doi.org\/10.1684\/ejd.2018.3243","journal-title":"Eur J Dermatol"},{"key":"1056_CR14","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/exd.14748","volume":"32","author":"R Ganji","year":"2023","unstructured":"Ganji R, Mahboubi-Fooladi Z, Shahidi-Dadras M, Tehranchinia Z, Abdollahimajd F, Ghalamkarpour F, et al. Brain MRI findings in patients with bullous pemphigoid: a case-control study. Exp Dermatol. 2023;32:542\u20136. https:\/\/doi.org\/10.1111\/exd.14748","journal-title":"Exp Dermatol"},{"key":"1056_CR15","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1111\/bjd.15405","volume":"176","author":"L Kibsgaard","year":"2017","unstructured":"Kibsgaard L, Rasmussen M, Lamberg A, Deleuran M, Olesen AB, Vestergaard C. Increased frequency of multiple sclerosis among patients with bullous pemphigoid: a population-based cohort study on comorbidities anchored around the diagnosis of bullous pemphigoid. Br J Dermatol. 2017;176:1486\u201391. https:\/\/doi.org\/10.1111\/bjd.15405","journal-title":"Br J Dermatol"},{"key":"1056_CR16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s40257-017-0293-x","volume":"18","author":"MC Kwa","year":"2017","unstructured":"Kwa MC, Silverberg JI. Association between inflammatory skin disease and cardiovascular and cerebrovascular co-morbidities in US adults: analysis of nationwide inpatient sample data. Am J Clin Dermatol. 2017;18:813\u201323. https:\/\/doi.org\/10.1007\/s40257-017-0293-x","journal-title":"Am J Clin Dermatol"},{"key":"1056_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.5336\/dermato.2018-61536","volume":"28","author":"Z A\u015fIran Serdar","year":"2018","unstructured":"A\u015fIran Serdar Z, Akta\u015f Karabay E, Ya\u015far S, Kazaz N. Clinical features, associated systemic diseases, mortality rates, and treatment protocols in a group of Turkish patients with bullous pemphigoid. Turk Klin Dermatol \u00d6zel. 2018;28:44\u201350. https:\/\/doi.org\/10.5336\/dermato.2018-61536","journal-title":"Turk Klin Dermatol \u00d6zel"},{"key":"1056_CR18","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/ced.13902","volume":"44","author":"A Kalinska-Bienias","year":"2019","unstructured":"Kalinska-Bienias A, Piotrowski T, Kowalczyk E, Lesniewska A, Kaminska M, Jagielski P, et al. Actigraphy-measured nocturnal wrist movements and assessment of sleep quality in patients with bullous pemphigoid: a pilot case\u2013control study. Clin Exp Dermatol. 2019;44:759\u201365. https:\/\/doi.org\/10.1111\/ced.13902","journal-title":"Clin Exp Dermatol"},{"key":"1056_CR19","doi-asserted-by":"publisher","first-page":"e15031","DOI":"10.1111\/dth.15031","volume":"34","author":"S K\u0131l\u0131\u00e7 Sayar","year":"2021","unstructured":"K\u0131l\u0131\u00e7 Sayar S, Sun GP, K\u00fc\u00e7\u00fcko\u011flu R. Comorbidities of bullous pemphigoid: a single-center retrospective case\u2013control study from Turkey. Dermatol Ther. 2021;34:e15031 https:\/\/doi.org\/10.1111\/dth.15031","journal-title":"Dermatol Ther"},{"key":"1056_CR20","doi-asserted-by":"publisher","first-page":"108546","DOI":"10.1016\/j.diabres.2020.108546","volume":"171","author":"CY Wu","year":"2021","unstructured":"Wu CY, Wu CY, Li CP, Chou YJ, Lin YH, Chang YT. Association between dipeptidyl peptidase-4 inhibitors and risk of bullous pemphigoid in patients with type 2 diabetes: a population-based cohort study. Diabetes Res Clin Pract. 2021;171:108546 https:\/\/doi.org\/10.1016\/j.diabres.2020.108546","journal-title":"Diabetes Res Clin Pract"},{"key":"1056_CR21","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1111\/ddg.14738","volume":"20","author":"E Martin","year":"2022","unstructured":"Martin E, Mauer I, Malzahn U, Heuschmann PU, Goebeler M, Benoit S. Comorbid diseases among bullous pemphigoid patients in Germany: new insights from a case-control study. J Dtsch Dermatol Ges. 2022;20:798\u2013805. https:\/\/doi.org\/10.1111\/ddg.14738","journal-title":"J Dtsch Dermatol Ges"},{"key":"1056_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1001\/jamadermatol.2021.5125","volume":"158","author":"WC Shen","year":"2022","unstructured":"Shen WC, Chiang HY, Chen PS, Lin YT, Kuo CC, Wu PY. Risk of all-cause mortality, cardiovascular disease mortality, and cancer mortality in patients with bullous pemphigoid. JAMA Dermatol. 2022;158:167\u201375. https:\/\/doi.org\/10.1001\/jamadermatol.2021.5125","journal-title":"JAMA Dermatol"},{"key":"1056_CR23","first-page":"7","volume":"31","author":"H Titou","year":"2022","unstructured":"Titou H, Kerrouch H, Frikh R, Hjira N. The association between bullous pemphigoid and comorbidities: a case-control study in Moroccan patients. Acta Dermatovenerol Alp Pannonica Adriat. 2022;31:7\u201311.","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"key":"1056_CR24","doi-asserted-by":"publisher","first-page":"204062232211307","DOI":"10.1177\/20406223221130707","volume":"13","author":"B Zhang","year":"2022","unstructured":"Zhang B, Chen X, Liu Y, Chen F, Yang N, Li L. Relationship between bullous pemphigoid and metabolic syndrome: a 12-year case-control study conducted in China. Ther Adv Chronic Dis. 2022;13:20406223221130707 https:\/\/doi.org\/10.1177\/20406223221130707","journal-title":"Ther Adv Chronic Dis"},{"key":"1056_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jdin.2023.04.014","volume":"13","author":"HA Stirnadel-Farrant","year":"2023","unstructured":"Stirnadel-Farrant HA, Xu X, Kwiatek J, Jain P, Meyers J, Candrilli S, et al. Characteristics, treatment patterns, health care resource utilization and costs in patients with bullous pemphigoid: a retrospective analysis of US health insurance claims data. JAAD Int. 2023;13:117\u201325. https:\/\/doi.org\/10.1016\/j.jdin.2023.04.014","journal-title":"JAAD Int"},{"key":"1056_CR26","doi-asserted-by":"publisher","first-page":"WC5","DOI":"10.7860\/jcdr\/2023\/64111.18091","volume":"17","author":"S Sumitra","year":"2023","unstructured":"Sumitra S, Chandran R, George AE. Proportion of Co-morbidities in patients with and without bullous pemphigoid: a cross-sectional study. J Clin Diagn Res. 2023;17:WC5\u2013WC8. https:\/\/doi.org\/10.7860\/jcdr\/2023\/64111.18091","journal-title":"J Clin Diagn Res"},{"key":"1056_CR27","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00403-022-02372-w","volume":"315","author":"PC Wu","year":"2023","unstructured":"Wu PC, Wu CY, Lyu YS, Chang YT, Wu CY. Association between bullous pemphigoid and atopic dermatitis: a population-based case-control study in Taiwan. Arch Dermatol Res. 2023;315:419\u201327. https:\/\/doi.org\/10.1007\/s00403-022-02372-w","journal-title":"Arch Dermatol Res"},{"key":"1056_CR28","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/jid.2010.301","volume":"131","author":"S Bastuji-Garin","year":"2011","unstructured":"Bastuji-Garin S, Joly P, Lemordant P, Sparsa A, Bedane C, Delaporte E, et al. Risk factors for bullous pemphigoid in the elderly: a prospective case\u2013control study. J Invest Dermatol. 2011;131:637\u201343. https:\/\/doi.org\/10.1038\/jid.2010.301","journal-title":"J Invest Dermatol"},{"key":"1056_CR29","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/ddg.14097","volume":"18","author":"E Schmidt","year":"2020","unstructured":"Schmidt E, Sticherling M, S\u00e1rdy M, Eming R, Goebeler M, Hertl M, et al. S2k guidelines for the treatment of pemphigus vulgaris\/foliaceus and bullous pemphigoid: 2019 update. J Dtsch Dermatol Ges. 2020;18:516\u201326. https:\/\/doi.org\/10.1111\/ddg.14097","journal-title":"J Dtsch Dermatol Ges"},{"key":"1056_CR30","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2165\/00002018-200730100-00005","volume":"30","author":"L Fardet","year":"2007","unstructured":"Fardet L, Kassar A, Cabane J, Flahault A. Corticosteroid-induced adverse events in adults: frequency, screening and prevention. Drug Saf. 2007;30:861\u201381. https:\/\/doi.org\/10.2165\/00002018-200730100-00005","journal-title":"Drug Saf"},{"key":"1056_CR31","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1365-2796.1994.tb00855.x","volume":"236","author":"HO Conn","year":"1994","unstructured":"Conn HO, Poynard T. Corticosteroids and peptic ulcer: meta-analysis of adverse events during steroid therapy. J Intern Med. 1994;236:619\u201332. https:\/\/doi.org\/10.1111\/j.1365-2796.1994.tb00855.x","journal-title":"J Intern Med"},{"key":"1056_CR32","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41371-024-00971-w","volume":"39","author":"OG Aremu","year":"2025","unstructured":"Aremu OG, Asowata OJ, Danladi DK, Okekunle AP, Akpa OM. Sleep quality and hypertension in an indigenous African population: a cross-sectional investigation from the COMBAT-CVDs study. J Hum Hypertens. 2025;39:164\u201370. https:\/\/doi.org\/10.1038\/s41371-024-00971-w","journal-title":"J Hum Hypertens"},{"key":"1056_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ajh\/hpab146","volume":"35","author":"JM Bock","year":"2022","unstructured":"Bock JM, Vungarala S, Covassin N, Somers VK. Sleep duration and hypertension: epidemiological evidence and underlying mechanisms. Am J Hypertens. 2022;35:3\u201311. https:\/\/doi.org\/10.1093\/ajh\/hpab146","journal-title":"Am J Hypertens"},{"key":"1056_CR34","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.autrev.2017.03.010","volume":"16","author":"IS Ba\u011fc\u0131","year":"2017","unstructured":"Ba\u011fc\u0131 IS, Horv\u00e1th ON, Ruzicka T, S\u00e1rdy M. Bullous pemphigoid. Autoimmun Rev. 2017;16:445\u201355. https:\/\/doi.org\/10.1016\/j.autrev.2017.03.010","journal-title":"Autoimmun Rev"},{"key":"1056_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep37125","volume":"6","author":"A-K F\u00f6rsti","year":"2016","unstructured":"F\u00f6rsti A-K, Jokelainen J, Ansakorpi H, Sepp\u00e4nen A, Majamaa K, Timonen M, et al. Psychiatric and neurological disorders are associated with bullous pemphigoid \u2013 a nationwide finnish care register study. Sci Rep. 2016;6:37125 https:\/\/doi.org\/10.1038\/srep37125","journal-title":"Sci Rep"},{"key":"1056_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/bjd.20661","volume":"186","author":"M Yousaf","year":"2021","unstructured":"Yousaf M, Ayasse M, Ahmed A, Gwillim EC, Janmohamed SR, Yousaf A, et al. Association between atopic dermatitis and hypertension: a systematic review and meta\u2010analysis*. Br J Dermatol. 2021;186:227\u201335. https:\/\/doi.org\/10.1111\/bjd.20661","journal-title":"Br J Dermatol"},{"key":"1056_CR37","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1111\/ajd.14355","volume":"65","author":"K Kridin","year":"2024","unstructured":"Kridin K, Goychberg R, Kridin M, Kafri N, Barhoum M, Cohen AD. The cardiovascular risk in bullous pemphigoid: insights from a population-based study. Australas J Dermatol. 2024;65:e187\u2013e93. https:\/\/doi.org\/10.1111\/ajd.14355","journal-title":"Australas J Dermatol"},{"key":"1056_CR38","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41371-022-00772-z","volume":"37","author":"E Kringeland","year":"2023","unstructured":"Kringeland E, Gerdts E, Ulvik A, Tell GS, Igland J, Haugsgjerd TR, et al. Inflammation, sex, blood pressure changes and hypertension in midlife: the Hordaland health study. J Hum Hypertens. 2023;37:718\u201325. https:\/\/doi.org\/10.1038\/s41371-022-00772-z","journal-title":"J Hum Hypertens"},{"key":"1056_CR39","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2133.2008.08880.x","volume":"160","author":"AV Marzano","year":"2009","unstructured":"Marzano AV, Tedeschi A, Fanoni D, Bonanni E, Venegoni L, Berti E, et al. Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications. Br J Dermatol. 2009;160:266\u201372. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08880.x","journal-title":"Br J Dermatol"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01056-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01056-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01056-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T10:03:58Z","timestamp":1757498638000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01056-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":39,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["1056"],"URL":"https:\/\/doi.org\/10.1038\/s41371-025-01056-y","relation":{},"ISSN":["1476-5527"],"issn-type":[{"type":"electronic","value":"1476-5527"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"4 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval was waived by the Ethics Committee of Anhui Medical University since the study did not involve any patient-specific information. All methods were performed in accordance with the relevant guidelines and regulations. No experiments involving human participants were performed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}